Key result
During the first stage of labour, the use of an oxytocin infusion was associated with a significant increase in suspicious or pathological fetal heart rate patterns compared to no oxytocin.
Answers are grounded in this paper and cite their sources.
In this reply discussing labour analgesia, the authors note that oxytocin use during the first stage of labour is associated with a significant increase in fetal heart rate abnormalities.
We thank Jain et al. for their interest in our paper 1, and for the discussion points raised. We decided to use 2.5 ml premixed bupivacaine 0.1%/fentanyl 2 μg.ml−1 because this is used at our hospitals for combined spinal-epidural (CSE) anaesthesia, and so was familiar to anaesthetists. Clearly, our results cannot be generalised to other dosing regimens. We believe that this dose is adequate since it has been shown that the ED50 of plain bupivacaine with 5 μg fentanyl in the first stage of labour is 0.69 mg 2, and that the addition of doses of fentanyl greater than 5 μg do not confer an advantage with respect to quality of analgesia, though duration of analgesia is increased in a dose-dependent manner 2. Importantly, the use of higher doses of fentanyl is not associated with a bupivacaine dose-sparing effect. The ED95 for plain bupivacaine with 15 μg fentanyl is 1.66 μg 3. Since the dose we used was significantly above both ED50 and ED95, we do not believe that this easily explains why a proportion of parturients in the CSE group experienced ineffective analgesia. Fourteen percent of the epidural group also experienced ineffective analgesia following the initial injection. It is well recognised that maximal analgesia following either CSE or epidural in labour is never achieved in 100% of women initially, although the proportion of ineffective blocks in our study is higher than documented previously 4. In our study, rescue analgesia was deferred until assessment 30 min after injection, because this is a time point that has been used previously in similar studies and allows the maximal effect of injection to be attained. This time period also reflects both our hospitals' normal clinical practice and National Institute for Health and Care Excellence (NICE) guidelines, which recommend an interval of 30 min following epidural top-up before an anaesthetist is called to provide rescue analgesia 5. Nine (15%) parturients in the CSE group and 12 (23%) of those in the epidural group received an oxytocin infusion during the first stage of labour. Subgroup analysis using Generalised Cochran-Mantel-Haenszel tests revealed the presence of suspicious or pathological fetal heart rate (FHR) patterns in 9 (41%) of those receiving oxytocin compared with only 10 (11%) without oxytocin. We conclude that the use of oxytocin is associated with a significant increase in FHR abnormalities (p = 0.004). Maternal blood pressure was measured at baseline and then at 5-min intervals for the first 15 min following neuraxial block by the midwife looking after the patient, as is standard care. This is in line with departmental and NICE guidelines 5. For the purpose of the study, blood pressure was recorded 15 min and 30 min after neuraxial injection by the third anaesthetist who was blinded to the procedure performed. It is therefore conceivable that brief periods of hypotension may have gone unnoticed. We agree that further research is warranted in order to determine the optimal dosing regimen for labour analgesia, combining rapid onset of long-acting analgesia with minimal effect on fetal heart rate.
No takes yet. Share an insight, caveat, or question.
El‐Wahab et al. (2014) conducted a letter in Labour. Oxytocin infusion vs. No oxytocin was evaluated on Suspicious or pathological fetal heart rate (FHR) patterns (p=0.004). During the first stage of labour, the use of an oxytocin infusion was associated with a significant increase in suspicious or pathological fetal heart rate patterns compared to no oxytocin.
Synapse has enriched 10 related papers. Consider them for comparative context: